BeOne Medicines Ltd. (ONC) operating KPIs
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$370.33−1.23 (-0.33%)
Close on Oct 30, 2026Market cap $42.11BP/E 66.2Yield –
BeOne Medicines collaboration R&D Service Revenue ($M, FY16–FY22) ($M)
Form 10-Q / 10-K Collaboration Note
Latest, Q3 2023
59
Period ended Sep 30, 2023
Change on a year earlier
+502.0%
9.80 in Q3 2022
History
25 quarters
Since Q3 2017
Sources
18
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). BeOne Medicines Collaboration R&D Service Revenue ($M, FY16–FY22) ($M), quarterly Q3 2017–Q3 2023 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/rev_collab_rd_service
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.